Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment.

Postepy higieny i medycyny doświadczalnej (Online)

Volumn 61, Issue , 2007, Pages 461-465

  Miedzybrodzki, Ryszard ^a   Fortuna, Wojciech ^a   Weber Dabrowska, Beata ^a   Górski, Andrzej ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; AMBULATORY CARE; ARTICLE; BACTERIOPHAGE TYPING; BIOSYNTHESIS; CLASSIFICATION; COMMUNICABLE DISEASE; COMPARATIVE STUDY; COST; DRUG COST; ECONOMICS; FEASIBILITY STUDY; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEALTH CARE COST; HOSPITAL COST; HUMAN; LEGAL ASPECT; LENGTH OF STAY; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; ORAL DRUG ADMINISTRATION; PHARYNGITIS; POLAND; STANDARD; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS PHAGE; TREATMENT OUTCOME; VIROLOGY;

ADMINISTRATION, ORAL; ADULT; AGED; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; BACTERIOPHAGE TYPING; COMMUNITY-ACQUIRED INFECTIONS; COSTS AND COST ANALYSIS; DRUG COSTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEASIBILITY STUDIES; FEMALE; HEALTH CARE COSTS; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHARYNGITIS; POLAND; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS PHAGES; TREATMENT OUTCOME;

EID: 34548431799     PISSN: None     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Article

References (0)